Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

HealthStream Q1 Profit Declines

RELATED NEWS
Trade HSTM now with 

HealthStream Inc. (HSTM: Quote) reported first-quarter net income of $1.4 million or $0.05 per share, down from $1.5 million or $0.07 per share last year

On average, analysts polled by Thomson Reuters expected earnings of $0.06 per share for the quarter. Analysts' estimates typically exclude special items.

Revenue for the quarter rose 28 percent to $23.7 million from $18.5 million a year ago.

Analysts expected revenues of $22.75 million for the quarter. Looking ahead, the company reiterated its previous guidance and anticipates a 21-25 percent increase in consolidated revenues for the full year 2012 compared to the previous year. The company expects a 20-26 percent increase in year-over-year operating income .

Click here to receive FREE breaking news email alerts for Healthstream Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Republicans have not found much to like about President Barack Obama's nearly six years in office, but the results of a new Washington Post-ABC News poll show that a vast majority support the president's decision to launch airstrikes in Iraq. While stocks have largely maintained a positive bias over the course of the trading day on Thursday, the major averages are turning in a mixed performance in mid-day trading. The S&P 500 has reached a new record intraday high and the Dow has climbed back above 17,000, while the tech-heavy Nasdaq is posting a modest loss. Suggesting that the economy is gaining traction, the Conference Board released a report on Thursday showing a bigger than expected increase by its index of leading U.S. economic indicators in July.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.